Combining Serum DNA Methylation Biomarkers and Protein Tumor Markers Improved Clinical Sensitivity for Early Detection of Colorectal Cancer

Figure 1

Positive detection rates of mSEPT9, mSDC2, and combined ColoDefense tests for detecting different disease states.